AzTrials
AzTrials

Healthy Participants With Different Skin Types and Different AgesNCT01980264

Harmonics-based in Vivo Optical Virtual Biopsy

A study testing Harmonic Generation Microscopy in people with Healthy Participants With Different Skin Types and Different Ages and Diseased Participants With Different Skin Types and Different Ages, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The research aims to study the molecules and structures in human skin by the image formation of harmonic-based in vivo optical virtual biopsy. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
What is being tested?
Harmonic Generation Microscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteTaiwan
Study dates
5 Aug 2009to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy volunteers of different skin colors and different ages
  • patients with suspected melanoma
  • patients with suspected basal cell carcinoma or squamous cell carcinoma
  • patients with diabetes mellitus

Who cannot join

  • volunteers have infectious disease
  • volunteers' skin have been infected with ulceration

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • Department of Dermatology, National Taiwan University Hospital and College of Medicine, National Taiwan University

    Taipei, 10002

    Recruiting

Other trials in Taiwan

About this study

The research aims to study the molecules and structures in human skin by the image formation of harmonic-based in vivo optical virtual biopsy.

Read the detailed description

In the research, the investigators use the Cr:forsterite laser as the light source, and utilize the nonlinear optical microscopic system to observe human skin via in vivo detection. In this study, images of human skin tissue will be acquired by virtual section to truly evaluate the feasibility of this system in clinical application.

This research intends to conduct the following research:

  1. To study the feasibility of this technology to observe melanin in the skin: As melanin is THG-bright, the technology will help to explore the distribution and change of melanin in the skin.
  2. To study the capability of this technology in the early diagnosis of skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma: By obtaining skin images of healthy and diseased patients, we can establish an image database of normal and cancerous skin in different atages, and evaluate the efficacy of this technology for early diagnosis of skin malignancy in the future.
  3. To study the ability of this technology to observe and analyze the degree of skin aging: Optical sectioning of human skin in a non-invasive in vivo manner can be used to detect the microscopic changes of skin aging and solar damage, and to find out the indicators of skin aging, so as to be used in the future to assist the therapeutic analysis of anti-skin aging treatment.
  4. To study the ability of this technology to observe peripheral vasculopathy and molecular changes of microvascular structures in diabetic patients: Perform microscopic imaging on healthy and diabetes patients' skin to observe effects of structures and molecules in their skin, such as peripheral vasculopathy in diabetic patients, and the status of disease parameters, with a view to find the cause of peripheral vascular lesions and other biological information.
Being tested
Harmonic Generation Microscopy
Keywords
Healthy human skin, Skin cancer, Melanoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Diabetes mellitus
Medical subject headings
Skin Neoplasms, Melanoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Harmonic Generation MicroscopyDevice

    Also called HGM

    Harmonic Generation Microscopy is a nonlinear optical microscopy.

Study groups in NCT01980264
Study groupRoleWhat they receive
Diagnostic imagingExperimentalHarmonic Generation Microscopy
Receives: Device: Harmonic Generation Microscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To noninvasively provide real-time imaging of cutaneous histopathology and molecular changes.

    To observe some analyzed molecule (melanin density, HbA1c density, collagen density, etc) \& structure (cell size, cell height, height of rete ridges, layer thickness, etc) parameters for different skin types \& age groups. (the information above can be observed in the nonlinear images) (Cell or molecule density is defined as the cell or molecule numbers in the specific image area) (Structure can be observed and reconstructed via multiple z-depth images)

    Measured: one year

Secondary outcomes (1)
  1. To provide a diagnostic tool for diseases.

    To diagnose if the analyzed pathological-related parameters (the parameters can be observed in the nonlinear images) (the pathological-related information includes cell shape, cell size, and molecular distribution (ex: chromatin, HbA1c, etc) in each single cell, etc) from Harmonic-based in Vivo Optical Virtual Biopsy can distinguish melanoma, basal cell carcinoma, squamous cell carcinoma, high \& low HbA1c groups from control.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2013 (estimated)
  2. Study start5 Aug 2009
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01980264
Sponsor's protocol ID
200903064D
Status last verified
Jun 2024
First submitted
3 Nov 2013
Last updated
21 Aug 2024
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Harmonic Generation Microscopy in people with Healthy Participants With Different Skin Types and Different Ages and Diseased Participants With Different Skin Types and Different Ages, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yi-Hua Liao, Doctoral ((02)23123456 ext. 263155, yihualiao@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To noninvasively provide real-time imaging of cutaneous histopathology and molecular changes. (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in